$ISIS Recent News Strong bull trend absorbs Fe
Post# of 44838
Posted On: 11/16/2014 12:23:21 PM
$ISIS Recent News
Strong bull trend absorbs Fed-induced whipsaw 9:59 a.m. Oct. 30, 2014 - Michael Ashbaugh
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 11:01 p.m. Sept. 1, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 8:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 10:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt
Isis/AstraZeneca Expand Antisense Technology Collaboration - Analyst Blog 4:30 p.m. Nov. 14, 2014 - Zacks.com
Cramer's Lightning Round - VeriFone Is Going To Have A Big Year (11/12/14) 9:05 a.m. Nov. 13, 2014 - Seeking Alpha
'Mad Money' Lightning Round: VeriFone Is Integral to ApplePlay 6:00 a.m. Nov. 13, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ARNA ISIS ACAD PBYI 5:45 a.m. Nov. 13, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Pining for Quiet Stock That Climbs 8:57 p.m. Nov. 12, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Highlighted As Today's Perilous Reversal Stock 9:48 a.m. Nov. 12, 2014 - TheStreet.com
Cramer's Mad Money - The Hottest Stock You've Never Heard Of (11/11/14) 5:20 a.m. Nov. 12, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Pile Into Housing, Biotech and Pop Cult Names 8:59 p.m. Nov. 11, 2014 - TheStreet.com
One Reason Isis Pharmaceuticals (ISIS) Stock Is Gaining Today 11:24 a.m. Nov. 11, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Is Strong On High Volume Today 10:02 a.m. Nov. 11, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ICUI ISIS NPSP PDLI 6:30 a.m. Nov. 11, 2014 - InvestorPlace.com
ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q3 2014 Results - Earnings Call Transcript 6:52 p.m. Nov. 7, 2014 - Seeking Alpha
Will Isis Pharmaceuticals (ISIS) Disappoint on Q3 Earnings? - Analyst Blog 6:00 p.m. Nov. 5, 2014 - Zacks.com
Cramer Sees HP Entering Sector as Trouble for 3-D Printing Stocks 11:57 a.m. Nov. 3, 2014 - TheStreet.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 30, 2014 - Zacks.com
Cramer's Lightning Round: Isis Is Still Good (10/29/14) 7:43 a.m. Oct. 30, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Stay Away From Applied Materials 6:00 a.m. Oct. 30, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Where to Find Bargains Created by the Fed 8:12 p.m. Oct. 29, 2014 - TheStreet.com
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14) 6:59 a.m. Oct. 29, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals 6:00 a.m. Oct. 29, 2014 - TheStreet.com
Isis Pharmaceuticals to Present at Upcoming Investor Conferences 7:00 a.m. Nov. 14, 2014 - PR Newswire - PRF
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods 3:01 a.m. Nov. 13, 2014 - PR Newswire - PRF
Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes 7:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Announces Proposed Offering of $425 Million of Convertible Senior Notes 4:03 p.m. Nov. 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca 7:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 4:05 p.m. Nov. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $5 Million in Milestone Payment From GSK for Advancement of ISIS-GSK5 Rx 7:00 a.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 8:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Critical Alerts For AT&T, SolarWinds, Whole Foods Market, FireEye and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 30, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 7:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
Regulus Announces Pricing of Public Offering of Common Stock 8:10 p.m. Oct. 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $18 Million From GSK for Advancing ISIS-TTR Rx 7:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
Critical Alerts For petroleo brasileiro, Herbalife, Micron, FireEye and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 7, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 7:00 a.m. Oct. 2, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx 7:00 a.m. Oct. 1, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Partners Rare Disease Roundtable 7:00 a.m. Sept. 24, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 8:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
Strong bull trend absorbs Fed-induced whipsaw 9:59 a.m. Oct. 30, 2014 - Michael Ashbaugh
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 11:01 p.m. Sept. 1, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 8:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 10:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt
Isis/AstraZeneca Expand Antisense Technology Collaboration - Analyst Blog 4:30 p.m. Nov. 14, 2014 - Zacks.com
Cramer's Lightning Round - VeriFone Is Going To Have A Big Year (11/12/14) 9:05 a.m. Nov. 13, 2014 - Seeking Alpha
'Mad Money' Lightning Round: VeriFone Is Integral to ApplePlay 6:00 a.m. Nov. 13, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ARNA ISIS ACAD PBYI 5:45 a.m. Nov. 13, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Pining for Quiet Stock That Climbs 8:57 p.m. Nov. 12, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Highlighted As Today's Perilous Reversal Stock 9:48 a.m. Nov. 12, 2014 - TheStreet.com
Cramer's Mad Money - The Hottest Stock You've Never Heard Of (11/11/14) 5:20 a.m. Nov. 12, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Pile Into Housing, Biotech and Pop Cult Names 8:59 p.m. Nov. 11, 2014 - TheStreet.com
One Reason Isis Pharmaceuticals (ISIS) Stock Is Gaining Today 11:24 a.m. Nov. 11, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Is Strong On High Volume Today 10:02 a.m. Nov. 11, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ICUI ISIS NPSP PDLI 6:30 a.m. Nov. 11, 2014 - InvestorPlace.com
ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q3 2014 Results - Earnings Call Transcript 6:52 p.m. Nov. 7, 2014 - Seeking Alpha
Will Isis Pharmaceuticals (ISIS) Disappoint on Q3 Earnings? - Analyst Blog 6:00 p.m. Nov. 5, 2014 - Zacks.com
Cramer Sees HP Entering Sector as Trouble for 3-D Printing Stocks 11:57 a.m. Nov. 3, 2014 - TheStreet.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 30, 2014 - Zacks.com
Cramer's Lightning Round: Isis Is Still Good (10/29/14) 7:43 a.m. Oct. 30, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Stay Away From Applied Materials 6:00 a.m. Oct. 30, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Where to Find Bargains Created by the Fed 8:12 p.m. Oct. 29, 2014 - TheStreet.com
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14) 6:59 a.m. Oct. 29, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals 6:00 a.m. Oct. 29, 2014 - TheStreet.com
Isis Pharmaceuticals to Present at Upcoming Investor Conferences 7:00 a.m. Nov. 14, 2014 - PR Newswire - PRF
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods 3:01 a.m. Nov. 13, 2014 - PR Newswire - PRF
Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes 7:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Announces Proposed Offering of $425 Million of Convertible Senior Notes 4:03 p.m. Nov. 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca 7:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 4:05 p.m. Nov. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $5 Million in Milestone Payment From GSK for Advancement of ISIS-GSK5 Rx 7:00 a.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 8:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Critical Alerts For AT&T, SolarWinds, Whole Foods Market, FireEye and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 30, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 7:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
Regulus Announces Pricing of Public Offering of Common Stock 8:10 p.m. Oct. 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $18 Million From GSK for Advancing ISIS-TTR Rx 7:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
Critical Alerts For petroleo brasileiro, Herbalife, Micron, FireEye and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 7, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 7:00 a.m. Oct. 2, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx 7:00 a.m. Oct. 1, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Partners Rare Disease Roundtable 7:00 a.m. Sept. 24, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 8:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼